Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Treatment Experience During Initiation of Subcutaneous Immunoglobulin Replacement (SCIG) Therapy at Home Using Alexa Skill

NCT06150534 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT06150534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06150534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Treatment Experience During Initiation of Subcutaneous Immunoglobulin Replacement (SCIG) Therapy at Home Using Alexa Skill
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
December 27, 2023
Completion date
February 28, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency diseases (pid)